Pyruvate Kinase Deficiency (PK Deficiency) is a hereditary blood disorder found more commonly in certain cat breeds due to a genetic mutation affecting red blood cell metabolism. This condition leads to a shortage of an essential enzyme called pyruvate kinase, which red blood cells need to produce energy. Without adequate energy, these cells break down prematurely, causing haemolytic anaemia and resulting in symptoms that can significantly impact a cat’s quality of life.
PK Deficiency is caused by an autosomal recessive gene mutation, meaning a cat must inherit two copies of the defective gene—one from each parent—to be affected. Cats with only one copy are carriers, often without symptoms but capable of passing the trait to offspring. Responsible breeding practices are crucial to prevent the spread of this condition.
Certain breeds have a higher predisposition to PK Deficiency. This includes Abyssinian, Somali, Bengal, Egyptian Mau, LaPerm, Maine Coon, Norwegian Forest, Savannah, Siberian, and Singapura cats. Notably, Abyssinian and Somali breeds are most affected and are subject to mandatory testing under some breed registries.
Reputable breeders perform genetic screening to identify carriers and affected cats, ensuring those cats are not used for breeding. This proactive approach reduces the likelihood of passing PK Deficiency to kittens, supporting healthier future generations.
Signs of PK Deficiency can vary, sometimes appearing early in life, other times later. Common symptoms include:
If you observe any of these signs in your cat, especially if of a predisposed breed, consult your vet promptly for evaluation.
Your vet will start with a thorough clinical history and physical exam, including questions about symptom onset and family background when possible.
Diagnostic tests typically include:
Genetic testing is widely available in the UK and is essential for responsible breeding and diagnosis confirmation.
Currently, the only curative treatment for PK Deficiency is a bone marrow transplant. However, this procedure is costly, not widely available, and carries significant risks.
Management focuses on supportive care, monitoring anaemia, and maintaining the best possible quality of life. Untreated affected cats typically have a shortened lifespan, often succumbing to complications by around four years of age.
For cats that undergo successful transplantation or whose condition is managed carefully, a normal life may be possible with proper veterinary care and a loving home.
Genetic screening helps distinguish between:
Mandatory testing policies exist for some breeds, such as the Somali under the GCCF in the UK, to encourage ethical breeding and reduce disease prevalence.
Pyruvate Kinase Deficiency is a serious inherited blood disorder predominantly affecting specific cat breeds like Abyssinians and Somalis. Awareness of the disease, early recognition of symptoms, and responsible breeders testing their cats for the PK gene mutation remain vital tools to minimise its impact. While treatment options are limited and costly, supportive care can improve affected cats' quality of life. If you're considering getting a cat, especially from predisposed breeds, ensure you find a reputable breeder who screens for genetic conditions or consider adopting from rescue centres.